---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-24-000232"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:51:56.218420+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Recursion CFO Ben Taylor gets $5M equity grant, enhanced vesting on Exscientia awards

## Summary
- Ben Taylor (CFO) enters employment letter with Exscientia AI Ltd, base salary £400K/year.
- Annual cash bonus target 25% of base salary; equity bonus target also 25%.
- New equity grant of $5M (50% RSUs, 50% options) vesting over 4 years, subject to board approval.
- Pre-existing Exscientia awards (Exchanged Awards) fully vest if terminated w/o cause or resign for good reason within 12 months of Nov 20, 2024 closing.
- Employment requires 3 months' notice/pay in lieu; garden leave may offset severance plan benefits.

## SEC filing metadata
- accession: 0001601830-24-000232
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000232/0001601830-24-000232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000232/rxrx-20241202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-24-000232
- JSON: https://secwatch.observer/filing/0001601830-24-000232.json
- Plain text: https://secwatch.observer/filing/0001601830-24-000232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.